7/29/2020, 1:16 PM (Source: TeleTrader)
more TeleTrader news

GSK reports sales of £7.6 billion in Q2

GlaxoSmithKline PLC (GSK) announced on Wednesday its sales in the second quarter of 2020 amounted to £7.6 billion, marking a 3% decline compared to the same period a year ago. The company attributed the fall in sales to disruptions caused by the COVID-19 pandemic.

Earnings per share (EPS) stood at 45.5 pence, while adjusted EPS slid 38% to 19.2 pence.

"The fundamentals of GSK’s business remain strong and we are maintaining good momentum on our strategic priorities," CEO Emma Walmsley stated. "We continue to believe that multiple options will be needed to prevent and treat COVID-19 and are working at pace with our partners to develop potential adjuvanted vaccines and therapeutics to fight the virus," she added.

Breaking the News / NP